The rasH2 mouse is a hemizygous transgenic mouse carrying the c-Ha-ras oncogene and that gene's promotor/enhancer within the genetic background of a BALB/cByJ C57BL/6J F1 mouse. Approximately 3 copies of the transgene are integrated in a tandem array into chromosome number 15. The transgene is transmitted stably without point mutation in hot spots and is expressed in all tissues over 20 backcross generations. The homozygous c-Ha-ras genotype is lethal. Hemizygotes are selected by polymerase chain reaction (PCR) analysis of tail tips after birth. Spontaneous tumors in hemizygous transgenic mice are rare until 6 months of age. The observed rasH2 tumor spectrum, including lung adenoma/adenocarcinoma, forestomach and skin papillomas, Harderian gland adenoma, liver proliferative lesions, splenic hemangioma/sarcoma, and lymphoma is consistent with the BALB/c and C57BL/6 background. In the rasH2 mouse, point mutations of the transgene induced by genotoxins are reported frequently but not in all tumors. Elevated levels of transgene expression were detected in all genotoxin-induced tumors in the rasH2. Increased transgene expression was independent of the mutation rate in transgenic and endogenous ras genes. These observations suggest that the overexpression of transgenic c-Ha-ras is responsible for accelerated tumor development.
Ando K., Saitoh A., Hino O., Takahashi R., Kimura M., Katsuki M. (1992). Chemically induced forestomach papillomas in transgenic mice carry mutant human c-Ha-ras transgenes. Cancer Res52: 978—982.
2.
Ariyoshi T. (2001). The rasH2 Transgenic Mouse: Nature of the Model and Mechanistic Study on Tumorigenesis. Toxicol Pathol29(Suppl.): xx—xx.
3.
Barbacid M. (1987). ras genes. Ann Rev Biochem56: 779—827.
4.
Bos LJ (1989). Ras oncogenes in human cancer: A review. Cancer Res49: 4682—4689.
5.
Chang EH, Furth ME, Scolnick EM, Lowy DR ( 1982). Tumorigenic transformation of mammalian cells induced by a normal human genehomologous to the oncogene of Harvey murine sarcoma virus. Nature297: 479—483.
6.
Chin L., Tam A., Pomerantz J., Wong M., Holash J., Bardeesy N., Shen Q., O'HaganR., Pantginis J., Zhou H., Horner JW, Cordon-Cardo C., Yancopoulos G., Depinho R. (1999). Essential role for oncogene Ras in tumour maintenance . Nature400: 468—472.
7.
Cohen JB, Levinson AD (1988). A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene . Nature334: 119—124.
8.
Doi S., Kimura M., Katsuki M. (1994). Site-specifi c mutation of the human c-Ha-ras transgene induced by dimethylbenzanthracene causes tissuespecifi c tumors in mice. Jpn J Cancer Res85: 801—807.
9.
Engelbergs J. , Thomale J., Rajewsky MF (2000). Role of DNA repair in carcinogen-induced ras mutation. Mutat Res450: 139—153.
10.
Hayashi S., Mori I., Nonoyama T., Mitsumori K. (1998). Point mutaions of the c-Ha-ras gene in spontaneous liver tumors of transgenic mice carrying the human c-Ha-ras Gene. Toxicol Pathol26: 556—561.
11.
Inoue R., Ushijima T., Katami M., Kushida H., Wakabayashi K., Sato H., Asamoto M., Katsuki M., Sugimura T., Nagao M. (1996). Rare activation of the human c-Ha-ras transgene of mice in hemangiendothelial sarcomas and liver tumors induced by Glu-P-1 . Jpn J Cancer Res87: 583—588.
12.
Maruyama C. , Yamazaki H., Tomisawa M., Urano K., Hioki K., Suemizu H., Wakana S., Ohnishi Y., Kijima H., Nakamura M., Ueyama Y., Tsuchida T., Mitsumori K., Nomura T., Tamaoki N. (2001). Overexpression of human H-ras transgene in tumors of rasH2 mice inducede by ethyl- and methylnitrosourea . Toxicol Pathol29(Suppl.): xx—xx.
13.
Maruyama C. , Tomisawa M., Wakana S., Yamazaki H., Suemizu H., Ohnishi Y., Uranao K., Hioki K., Usui T., Nakamura M., Tsuchida T., Mitsumori K., Nomura T., Tamaoki N., Ueyama Y. (2001). Overexpression of human H-ras transgene is responsible for tumors induced by chemical carcinogens in mice. Oncol Reports8: 233—237.
14.
Mitsumori K. , Wakana S., Yamamoto S., Kodama Y., Yasuhara K., Nomura T., Hayashi Y., MaronpotRR (1997). Susceptibilityoftransgenicmicecarrying human prototype c-Ha-ras gene in a short-term carcinogenicity study of vinyl carbamate and ras gene analyses of the induced tumors. Mol Carcinog20: 298—307.
15.
Mitsumori K. , Koizumi H., Nomura T., Yamamoto S. (1998). Pathological features of spontanenous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenesis studies. Toxicol Pathol26: 520—531.
16.
Nomura T, Esaki K, Tomita T (eds) (1980 ). ICLAS Manual for Genetic Monitoring of Inbred Mice. University of Tokyo Press, Tokyo, Japan, pp. 23—110.
17.
Ogawa K., Imaida K., Masui T., Kawabe M., Hasegawa R., Kato K., Ito N., Shirai T. (1996). Chemically induced lung and forestomach neoplasias in transgenic mice carry mutant forms of human c-Ha-ras transgene. Carcinogenesis17:341—345.
18.
Ohnishi Y., Arai T., Koshirakawa M., Horii N., Nakajo S., Ueyama Y., Urano K., Usui T., Nomura T. (2001). Induction of drug metabolism-related enzymes by methylcholanthrene and phenobarbital in transgeneic mice carrying human prototype c-Ha-ras gene and their wild type littermates. Exp Anim50: 33—39.
19.
Saitoh A., Kimura M., Takahashi R., Yokoyama M., Nomura T., Izawa M., Sekiya T., Nishimura S., Katsuki M. (1990). Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene5: 1195—1200.
20.
Sekiya T., Prassolov VS, Fushimi M., Nishimura S. (1985). Transforming activity of the c-Ha-ras oncogene having two point mutations in the codon 12 and 61. Jpn J Cancer Res76: 851—855.
21.
Suemizu H., Ohnishi Y., Maruyama C., Tomisawa M., Muguruma K., Hioki K., Usui T., Kimura M., Tamaoki N., Nomura T. (2001). Molecular biological studies in the rasH2 transgenic mouse. Toxicol Pathol29(suppl.): xx—xx.
22.
Tsunematsu S., Saito H., Kagawa T., Morizane T., Hata J., Nakamura T., Ishii H., Tsuchida M., Nomura T., Katsuki M. (1994). Hepatic tumors induced by carbon tetrachloride in transgenic mice carrying a human c-Ha-ras proto-oncogene without mutations. Int J Cancer15: 554—559.
23.
Usui T. ( 2001). Neonatal mouse madel: Overview of available data. (this volume).
24.
Vojtek AB, Der CJ (1998). Increasing complexity of the ras signaling pathway . J Biol Chem273: 19925—19928.
25.
Yamamoto S. , Urano K., Koizumi H., Wakana S., Hioki K., Mitsumori K., Kurokawa Y., Hayashi Y., Nomura T. (1998). Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. EnivironHealth Perspect106(Suppl. 1): 57—69.
